DR info

Clinical trial : 1 / Drugs : 10 - (DrugBank : 9) / Drug target genes : 6 - Drug target pathways : 73

Drugs and their primary sponsors and trial info

Adalimumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Certolizumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Etanercept
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Golimumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Infliximab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Leflunomide
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Methotrexate
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Pamidronate
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Sulfasalazine
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;
Zoledronic acid
   Seattle Children's Hospital
      2018   -   NCT04725422   United States;